Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/2/15 → 12/2/18 |
Funding
- PRA Health Sciences (GS-US-367-1172)
- Gilead Sciences, Inc. (GS-US-367-1172)
Prot #GS-US-367-1172: A Phase 3, Global, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 8 Weeks Compared to Sofosbuvir/Velpatasvir for 12 Weeks in Direct-Acting
- Flamm, Steven L (PD/PI)
Project: Research project